Adagene shares rise on buyback program
30/06/2022 12:06
** U.S.-listed shares of Adagene Inc ADAG.O up as much as
12.6% at $2.36 premarket
** The China-based drugmaker announced plan to repurchase up
to $10 mln of its ordinary shares in the form of American
depositary shares urn:newsml:reuters.com:*:nGNX8TfRxY
** ADAG has a market cap of about $91.8 mln and 43.8 mln
outstanding shares - Refinitiv
** Up to last close, stock had fallen 74% this year
(Reporting by Nandhini Srinivasan from Bengaluru)
((Nandhini.srinivasan@thomsonreuters.com))
Recent news on Adagene
See all newsBrief: Adagene To Begin Phase 1 Study Of ADG138 For Advanced Solid Tumors In Q4 2026
Brief: Adagene Announces That Third Arc Bio Has Selected First Lead Candidate Under Amended Strategic Collaboration For Development Of Masked Cd3 T Cell Engagers Utilizing Safebody® Technology
Brief: Adagene Inc Announces Offering Of American Depositary Shares
Brief: Adagene Announces FDA Fast Track Designation For Muzastotug (Adg126)
Brief: Adagene Expands SAFEBody Deal With Exelixis To Develop Third Novel Masked Antibody-Drug Conjugate